QSYMIA 3.75 MG-23 MG CAPSULE

phentermine and topiramate
$5.7651per EA
DEA Schedule CIV

Strength

3.75; 23 mg/1; mg/1

Manufacturer

Vivus LLC

NDC

62541020130

Classification

Brand

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Last Updated

6/22/2022

Approval Type

New Drug (NDA)

FDA Application

NDA022580

On Market Since

9/17/2012

Pharmacological Classes

Appetite Suppression
Cytochrome P450 2C19 Inhibitors
Cytochrome P450 3A4 Inducers
Decreased Central Nervous System Disorganized Electrical Activity
Increased Sympathetic Activity
Sympathomimetic Amine Anorectic

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

0.0%

5Y

-0.2%

All

+31.9%